The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending a CRISPR gene editing-based treatment for severe sickle cell disease (SCD). The regulator said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback